Meg Tirrell
Meg Tirrell
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
Antibody drugs used to treat Trump, others could cut Covid-19 hospitalizations by half, but they're not being used by the general public

Antibody drugs used to treat Trump, others could cut Covid-19 hospitalizations by half, but they're not being used by the general public

Key PointsOnly 5-20% of antibody drug doses shipped to states are used: Operation Warp SpeedWhen President Donald Trump got sick with Covid-19 in October, he credited an antibody drug from with making him feel better "immediately.""I felt as good three days ago as I do now," he said in a video shot in front of the White House after he left Walter Reed National Military Medical Center, promising medicines from Regeneron and would soon be available to the American public to help stop the terrible effects of Covid-19.20 hours agoThe concern, as these drugs were cleared through the FDA and made...

December 16, 2020
Share
Save
Review
No Rating
Flu shot makers plan to supply record numbers of vaccine doses amid Covid-19 pandemic

Flu shot makers plan to supply record numbers of vaccine doses amid Covid-19 pandemic

Key PointsIn this articleAs we await Covid-19 vaccines, flu shot makers are increasing outputFlu-shot manufacturers plan to ship record numbers of vaccine doses to the U.S. this year as public health officials prepare to urge as many Americans as possible to protect themselves amid the ."Though we don't yet have a vaccine for Covid, we do have a tool to prevent influenza," said Dr. Nancy Messonnier, director of the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases, in a recent podcast interview.The four makers of flu vaccines have said...

August 4, 2020
Share
Save
Review
No Rating
Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer

Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer

Key PointsRegeneron aims for COVID-19 drug trials by early summerBiotech giant said it aims to have doses of a potential drug for COVID-19 ready to start human clinical trials by early summer.The approach involves creating antibodies to the virus that could be used to treat the disease and to prevent it, Regeneron said in a statement Tuesday. The company had it aimed to have hundreds of thousands of doses ready for human testing in late summer, so the new goal is a significant acceleration. Regeneron said it plans to start large-scale manufacturing by the middle of next month and still...

March 17, 2020
Share
Save
Review
  • Total 3 items
  • 1
OUTLETS
cnbc.com

cnbc.com

CRITIC
img-contested
57%
PUBLIC
img-trusted
68%